Correction: The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer [Oncotarget., 7, (2016) (41217-41232)] doi: 10.18632/oncotarget.9251

Yusuke Shiozawa, Janice E. Berry, Matthew R. Eber, Younghun Jung, Kenji Yumoto, Frank C. Cackowski, Hyeun Joong Yoon, Princy Parsana, Rohit Mehra, Jingcheng Wang, Samantha McGee, Eunsohl Lee, Sunitha Nagrath, Kenneth J. Pienta, Russell S. Taichman

Research output: Contribution to journalComment/debate

Abstract

Present: The original figure 7 misspelled the word 'rapamycin. Correct: The proper spelling appears in the figure below. The authors sincerely apologize for this error.

Original languageEnglish (US)
Number of pages1
JournalOncotarget
Volume8
Issue number23
DOIs
StatePublished - Jan 1 2017

    Fingerprint

ASJC Scopus subject areas

  • Oncology

Cite this

Shiozawa, Y., Berry, J. E., Eber, M. R., Jung, Y., Yumoto, K., Cackowski, F. C., Yoon, H. J., Parsana, P., Mehra, R., Wang, J., McGee, S., Lee, E., Nagrath, S., Pienta, K. J., & Taichman, R. S. (2017). Correction: The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer [Oncotarget., 7, (2016) (41217-41232)] doi: 10.18632/oncotarget.9251. Oncotarget, 8(23). https://doi.org/10.18632/oncotarget.18369